Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

By Catherine Liu, A. Bayer, S. Cosgrove, Robert S. Daum, S. Fridkin, R. Gorwitz, S. Kaplan, A. Karchmer, D. Levine, B. Murray and 3 more. Clinical Infectious Diseases, 2011

1,585 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Infectious Diseases, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/f0a86d9675cc5b1a092456db4a38f8c9f194ae66

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

1. Victor J. Torres
2. Francis Alonzo

In Infectious Diseases

1. Victor J. Torres
2. Francis Alonzo
3. M. Otto

In Public Health, Environmental and Occupational Health

1. Victor J. Torres
2. Francis Alonzo
3. M. Otto

Citations in the corpus

• The Bicomponent Pore-Forming Leucocidins of Staphylococcus aureus (2014, background): “(4) Engagement of Toll-like receptors (TLR2 and TLR4) to stimulate the same canonical NF- B activation pathway described above (3).”
• Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 (2017, methodology): “These include situations in which there is a slow clinical response, undrainable foci of infection, bacteremia with S aureus (particularly MRSA) (67, 104), candidemia/invasive candidiasis (105) and other fungal infections, some viral infections (e.g., herpes, cytomegalovirus), and immunologic defici”
• Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association (2015, background): “Some experts recommend higher doses of daptomycin at 8 to 10 mg/ kg for complicated infections, including left-sided IE (these doses are not approved by the FDA).(109) This recommendation is based in part on evidence suggesting that higher-dose daptomycin may reduce the likelihood of treatment-emerg”
• Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management (2015, background): “In such dire settings, consideration can be given to unproven adjunctive therapies such as the intrathecal administration of vancomycin (796, 797) or the addition of antibiotics such as linezolid (CSF penetration, 66% [79]), TMP-SMX (CSF penetration, 50% [798]), or daptomycin (CSF penetration, 6% [7”